TMEM135 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.445600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.039000E-01
Normal-vs-Stage2
4.325200E-01
Normal-vs-Stage3
3.652800E-01
Normal-vs-Stage4
3.738600E-01
Stage1-vs-Stage2
9.535800E-01
Stage1-vs-Stage3
9.561600E-02
Stage1-vs-Stage4
4.874400E-01
Stage2-vs-Stage3
1.299960E-01
Stage2-vs-Stage4
3.150600E-01
Stage3-vs-Stage4
2.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.862600E-01
Normal-vs-AfricanAmerican
4.587900E-02
Normal-vs-Asian
7.784600E-01
Caucasian-vs-AfricanAmerican
4.042400E-03
Caucasian-vs-Asian
4.767400E-01
AfricanAmerican-vs-Asian
1.573810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.909200E-01
Normal-vs-Female
3.981200E-01
Male-vs-Female
6.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.364200E-01
Normal-vs-Age(41-60Yrs)
2.447600E-01
Normal-vs-Age(61-80Yrs)
5.411600E-01
Normal-vs-Age(81-100Yrs)
7.857400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.437000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.862800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.961800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.560400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.825800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.232400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.260000E-01
Normal-vs-Daily Drinker
6.191200E-01
Normal-vs-Weekly Drinker
9.818400E-01
Normal-vs-Occasional Drinker
2.978600E-01
Normal-vs-Social Drinker
5.124000E-01
Non Drinker-vs-Daily Drinker
5.486400E-01
Non Drinker-vs-Weekly Drinker
1.383970E-01
Non Drinker-vs-Occasional Drinker
6.769600E-01
Non Drinker-vs-Social Drinker
8.136200E-01
Daily Drinker-vs-Weekly Drinker
3.709600E-01
Daily Drinker-vs-Occasional Drinker
3.503800E-01
Daily Drinker-vs-Social Drinker
7.763000E-01
Weekly Drinker-vs-Occasional Drinker
7.237900E-02
Weekly Drinker-vs-Social Drinker
2.612800E-01
Occasional Drinker-vs-Social Drinker
5.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.446300E-02
Normal-vs-Grade 2
8.298000E-03
Normal-vs-Grade 3
7.522000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.041400E-01
Grade 1-vs-Grade 3
2.287800E-01
Grade 1-vs-Grade 4
3.446300E-02
Grade 2-vs-Grade 3
9.516000E-01
Grade 2-vs-Grade 4
8.298000E-03
Grade 3-vs-Grade 4
7.522000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.120000E-01
Normal-vs-NonDiabetic
4.438200E-01
Diabetic-vs-NonDiabetic
6.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.180000E-01
Normal-vs-NoPancreatitis
4.874800E-01
Pancreatitis-vs-NoPancreatitis
9.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.225000E-01
Normal-vs-N1
4.353400E-01
N0-vs-N1
9.158800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.981600E-01
Normal-vs-TP53-NonMutant
6.131600E-01
TP53-Mutant-vs-TP53-NonMutant
2.721400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
